Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

Ben Hargreaves looks at why insulin ... drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges for patients. By taking steps to hold ...

PBMs have long been seen as the “middlemen” getting in the ... 7 The FTC said that it is not targeting drug manufacturers for rising insulin prices, but it has not ruled out taking legal ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Hal Andrews, CEO at Trilliant Health, said as new drugs soared in popularity, drug companies have faced political pressure to ...

Explainer-Who in the US Benefits From $35 Insulin ... Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates with manufacturers ...

He said he feared new drug companies would be reluctant to make insulin over the long term because prices for the medication have dropped significantly. When Novo Nordisk slashed the prices of its ...